Peter Harris award lecture
History and prospects in calcium antagonist research

https://doi.org/10.1016/0022-2828(90)91458-JGet rights and content

First page preview

First page preview
Click to open first page preview

References (24)

  • G. Fleckenstein-Grün et al.

    Calcium antagonists: Mechanisms and therapeutic uses

    Trends in Pharmacological Sciences

    (1984)
  • A. Fleckenstein et al.

    The role of calcium in the pathogenesis of experimental arteriosclerosis

    Trends in Pharmacological Sciences (TIPS)

    (1987)
  • W.G. Nayler

    Biochemical aspects of prenylamine action. Preliminary communication

  • A. Fleckenstein et al.

    Influence of prenylamine on the utilization of high energy phosphates in cardiac muscle

  • A. Fleckenstein

    Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions

  • A. Fleckenstein

    Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle

    Ann Rev Pharmacol Toxicol

    (1977)
  • A. Fleckenstein
  • G. Grün et al.

    Die elektro-mechanische Entkoppelung der glatten Gefäßmuskulatur als Grundprinzip der Coronardilatation durch 4-(2′-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäure-dimethylester (Bay a 1040, Nifedipin)

    Arzneim.-Forsch. (Drug Res.)

    (1972)
  • G. Fleckenstein-Grün

    Role of transmembrane Ca2+ supply in phasic and tonic activation of vascular smooth muscle—Vasodilator efficacy of calcium antagonists

  • G. Fleckenstein-Grün et al.

    New pharmacological aspects of various dihydropyridine calcium antagonists with regard to smooth muscle relaxation

  • G. Fleckenstein-Grün

    Control of coronary spasm by calcium antagonists

  • G. Fleckenstein-Grün

    Suppression of experimental coronary spasms by major calcium antagonists

  • Cited by (15)

    View all citing articles on Scopus
    View full text